AKT1 and cancer: The inhibition of multiple molecular pathways such as PI3K/AKT/mTOR, nuclear factor kappa B (NF-kB) and STAT3 have been reported to be involved in its anti-cancer effect even if all the pathways involved remain to be elucidated [11].